MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Emergent Biosolutions Company Profile (NYSE:EBS)

Consensus Ratings for Emergent Biosolutions (NYSE:EBS) (?)
Ratings Breakdown: 1 Hold Rating(s), 3 Buy Rating(s)
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $43.67 (48.83% upside)

Analysts' Ratings History for Emergent Biosolutions (NYSE:EBS)
Show:
DateFirmActionRatingPrice TargetActions
6/22/2016Wells FargoReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2016Cowen and CompanyDowngradeOutperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/2/2016Chardan CapitalReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/28/2016Singular ResearchInitiated CoverageBuy$44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/6/2015Summer StreetReiterated RatingBuy$35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/12/2015JPMorgan Chase & Co.Boost Price TargetOverweight$32.00 -> $34.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/25/2014 forward)
Earnings History for Emergent Biosolutions (NYSE:EBS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
5/5/2016Q1($0.07)$0.16$101.83 million$111.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/25/2016Q4$0.70$0.78$168.07 million$168.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2015Q315$0.55$0.83$151.42 million$164.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q215$0.18$0.36$114.25 million$126.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/7/2015Q1($0.45)($0.50)$62.70 million$63.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/5/2015Q115$0.69$0.75$147.00 million$148.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/6/2014Q414$0.52$0.49$126.90 million$138.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/7/2014Q214$0.32$0.25$109.25 million$110.30 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2014Q114($0.14)($0.55)$57.30 million$53.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/6/2014Q413$0.36$0.42$93.83 million$94.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/7/2013Q313$0.21$0.37$79.13 million$89.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/5/2013Q2 2013$0.21$0.29$75.73 million$82.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/2/2013Q1 2013($0.14)($0.22)$46.17 million$43.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/7/2013Q4 2012$0.44$0.44$95.09 million$94.61 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/1/2012Q312$0.22$0.18$73.53 million$66.60 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/2/2012$0.21$0.21ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2012($0.18)($0.19)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/8/2012$0.72$0.78ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/3/2011($0.04)$0.04ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/4/2011$0.33$0.40ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/5/2011($0.52)($0.64)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
3/10/2011$0.67$0.76ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Emergent Biosolutions (NYSE:EBS)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Emergent Biosolutions (NYSE:EBS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Emergent Biosolutions (NYSE:EBS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
6/6/2016George A JoulwanDirectorSell4,700$44.12$207,364.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/1/2016Daniel Abdun-NabiCEOSell8,699$43.74$380,494.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/27/2016Fuad El-HibriMajor ShareholderSell9,835$43.50$427,822.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/26/2016Fuad El-HibriMajor ShareholderSell39,759$43.13$1,714,805.67View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Fuad El-HibriMajor ShareholderSell85,000$42.52$3,614,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/25/2016Zsolt HarsanyiDirectorSell27,867$42.33$1,179,610.11View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/24/2016Fuad El-HibriChairmanSell20,000$42.26$845,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/23/2016Fuad El-HibriChairmanSell45,000$42.62$1,917,900.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/20/2016Daniel Abdun-NabiCEOSell8,701$42.00$365,442.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/19/2016Jerome M HauerDirectorSell3,134$41.22$129,183.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2016Louis W SullivanDirectorSell47,631$39.21$1,867,611.51View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Fuad El-HibriMajor ShareholderSell25,000$38.71$967,750.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/12/2016Jerome M HauerDirectorSell4,700$38.50$180,950.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2016Louis W SullivanDirectorSell9,969$39.25$391,283.25View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/22/2016Fuad El-HibriMajor ShareholderSell4,209$40.50$170,464.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Daniel Abdun-NabiCEOSell8,702$40.17$349,559.34View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/18/2016Fuad El-HibriMajor ShareholderSell20,791$40.50$842,035.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Fuad El-HibriMajor ShareholderSell50,000$39.00$1,950,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/6/2016Robert KramerEVPSell21,786$38.90$847,475.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2016Robert KramerEVPSell21,788$36.90$803,977.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/1/2016Robert KramerEVPSell43,572$35.56$1,549,420.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Adam HaveyEVPSell4,359$33.96$148,031.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/14/2016Jerome M HauerDirectorSell2,350$33.88$79,618.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Adam HaveyEVPSell11,112$33.84$376,030.08View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2016Louis W SullivanDirectorSell14,879$34.03$506,332.37View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/7/2016Marvin L WhiteDirectorSell33,134$35.42$1,173,606.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/4/2016Sue BaileyDirectorSell11,520$38.79$446,860.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/30/2015Ronald RichardDirectorSell21,600$40.00$864,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/24/2015Daniel Abdun-NabiCEOSell63,209$39.06$2,468,943.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/19/2015Fuad El-Hibrimajor shareholderSell17,871$37.50$670,162.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/13/2015Fuad El-Hibrimajor shareholderSell13,013$36.50$474,974.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2015Barry LabingerEVPSell36,126$35.64$1,287,530.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/9/2015Fuad El-Hibrimajor shareholderSell13,225$35.50$469,487.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/6/2015Fuad El-Hibrimajor shareholderSell13,450$34.50$464,025.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/3/2015Fuad El-Hibrimajor shareholderSell13,689$33.50$458,581.50View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/11/2015Sue BaileyDirectorSell6,080$32.37$196,809.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/13/2015George A JoulwanDirectorSell7,200$34.72$249,984.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/20/2015Fuad El-HibriChairmanSell234$34.50$8,073.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/13/2015Ronald RichardDirectorSell4,922$34.00$167,348.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/29/2015Ronald RichardDirectorSell4,923$32.76$161,277.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/22/2015Fuad El-HibriMajor ShareholderSell74,564$32.60$2,430,786.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/16/2015Louis W SullivanDirectorSell13,457$31.33$421,607.81View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Adam HaveyEVPSell36,298$31.55$1,145,201.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/15/2015Fuad El-HibriMajor ShareholderSell45,436$32.18$1,462,130.48View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/20/2015Fuad El-HibriMajor ShareholderSell15,325$27.67$424,042.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/26/2014Ronald RichardDirectorSell5,000$28.00$140,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/17/2014Ronald RichardDirectorSell5,000$27.00$135,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/11/2014Fuad El-HibriMajor ShareholderSell119,341$26.00$3,102,866.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/28/2014Fuad El-HibriMajor ShareholderSell34,577$25.00$864,425.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Fuad El-HibriMajor ShareholderSell9,014$25.00$225,350.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/25/2014Zsolt HarsanyiDirectorSell8,000$24.82$198,560.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2014Fuad El-HibriMajor ShareholderSell2,311$25.00$57,775.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/7/2014Robert KramerCFOSell2,625$24.00$63,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/16/2014Robert KramerCFOSell50,189$24.34$1,221,600.26View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/12/2014Adam HaveyEVPSell11,562$27.50$317,955.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
3/11/2014Adam HaveyEVPSell17,655$26.96$475,978.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Emergent Biosolutions (NYSE:EBS)
DateHeadline
06/24/16 03:49 PMStock in Oversold Area: Emergent BioSolutions, Inc. (NYSE:EBS) - Press Telegraph
06/24/16 10:30 AMEmergent BioSolutions Inc. (EBS) Sank Sharply After Government Order
06/24/16 10:30 AMWhy is Emergent BioSolutions Inc. (EBS) Down 22% Today?
06/23/16 08:46 PMEmergent Biosolutions Inc. (EBS) Drops 20.32% on June 22 - Equities.com
06/23/16 02:41 PMStrong Sell Calls Recommendations For Emergent Biosolutions, Inc. (NYSE:EBS) At 0 - Investor Newswire
06/23/16 02:41 PMEmergent BioSolutions Inc. (EBS) Sank Sharply After Government Order - RTT News
06/23/16 02:41 PMAnalysts Observing Trading Stocks: Emergent Biosolutions, Inc. (NYSE:EBS) , Brookdale Senior Living Inc. (NYSE:BKD) - Street Updates
06/22/16 04:05 PMEmergent BioSolutions Stock Plunges On Light Anthrax Vaccine Order -
06/22/16 03:53 PM10 Biggest Mid-Day Losers For Wednesday - Benzinga
06/22/16 03:53 PMWhy is Emergent BioSolutions Inc. (EBS) Down 22% Today? - Nasdaq
06/22/16 03:33 PMWhy Emergent BioSolutions Inc. Procured a Lower Price Today -
06/22/16 01:00 PM10 Biggest Mid-Day Losers For Wednesday -   Emergent Biosolutions Inc (NYSE: EBS) shares dropped 21.54 percent to $30.85 after the company reported that the U.S. Department of Health and Human Services issued two solicitation notices with respect to the development and procurement of anthrax vaccines for the Strategic National Stockpile. Covenant Transportation Group, Inc. (NASDAQ: CVTI) shares tumbled 15.16 percent to $18.64 after the company lowered its Q2 earnings outlook. Ascent Capital Group Inc (NASDAQ: ASCMA) dropped 9.41 percent to $16.27. Imperial Capital downgraded Ascent Capital to ...Full story available on Benzinga.com
06/22/16 08:26 AMEmergent BioSolutions (EBS) Announces Completion of FDA PAI for Building 55; No Action Indicated - StreetInsider.com
06/21/16 08:23 AMFDA Completes Pre-Approval Inspection of Emergent BioSolutions’ Large-Scale Manufacturing Facility for BioThrax
06/21/16 08:23 AMEmergent BioSolutions (EBS) Announces Completion of FDA PAI for Building 55; No Action Indicated
06/20/16 09:57 AMEmergent Biosolutions, Inc. (NYSE:EBS) Analyst Price Targets For The Coming Week - Fiscal Standard
06/20/16 08:19 AM20.06.2016 - Hungary and EBRD acquire minority stakes in Erste Bank HungaryZrt. - [at noodls] - 20.06.2016 - Hungary and EBRD acquire minority stakes in Erste Bank HungaryZrt. The text version of this document is not available at the moment. The original content was posted at original link . Erste ...
06/20/16 08:13 AMEmergent (EBS) BioThrax sBLA Accepted for FDA Review -
06/20/16 07:14 AMEmergent BioSolutions, Inc. breached its 50 day moving average in a Bearish Manner : EBS-US : June 20, 2016 -
06/20/16 06:09 AMUnique: George Airbag Protects Against Cybercrime - [at noodls] - Protection against phishing and Trojans with George Airbag New George plans available Altogether five new plug-ins that make online banking easier The digital banking app George by Erste Bank und Sparkassen ...
06/18/16 08:17 AMEmergent BioSolutions: Underlying Value To Be Realized Following Aptevo Spin-Off
06/18/16 08:17 AMEmergent BioSolutions' (EBS) sBLA for BioThrax Manufacturing Accepted by U.S. FDA
06/17/16 09:19 AMFDA Accepts Emergent BioSolutions’ Supplemental Biologics License Application for Large-Scale Manufacturing of BioThrax in Building 55 - [at noodls] - GAITHERSBURG, Md., June 17, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced that the U.S. Food and Drug Administration (FDA) has accepted for review Emergent's supplemental ...
06/17/16 08:10 AMEmergent BioSolutions' (EBS) sBLA for BioThrax Manufacturing Accepted by U.S. FDA - StreetInsider.com
06/17/16 06:51 AMEmergent BioSolutions Says FDA Accepts Its sBLA For Large-Scale Manufacturing Of BioThrax In Building 55 -
06/16/16 03:45 PMEmergent Biosolutions, Inc. (NYSE:EBS) Current Analyst Ratings - Fiscal Standard
06/16/16 03:45 PMStrong Buy Calls Count For Emergent Biosolutions, Inc. (NYSE:EBS) At 4 - Investor Newswire
06/16/16 08:04 AMEmergent (EBS) BioThrax Gets Orphan Status in the U.S.
06/16/16 02:39 AM16.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 16.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
06/15/16 03:47 PMEmergent BioSolutions (EBS) Announces Orphan Drug status for BioThrax - StreetInsider.com
06/15/16 06:29 AMEmergent BioSolutions Receives FDA Orphan Drug Status for BioThrax for Post-Exposure Prophylaxis of Anthrax Disease - [at noodls] - GAITHERSBURG, Md., June 15, 2016 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug status for BioThrax (Anthrax ...
06/15/16 06:03 AM7:03 am Emergent BioSolutions announces FDA has granted Orphan Drug status for BioThrax for post-exposure prophylaxis of anthrax disease resulting from exposure to Bacillus anthracis -
06/14/16 08:29 AM14.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 14.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
06/09/16 11:05 AMEmergent Biosolutions Inc. (EBS) Hits New 52-week High During June 07 Session - Equities.com
06/09/16 05:09 AM09.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 09.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
06/08/16 02:41 PMEMERGENT BIOSOLUTIONS INC. (NYSE:EBS) Financial Condition Compared to S&P 500 - CML News
06/08/16 08:48 AMEmergent Biosolutions Inc. (EBS) Hits New 52-week High During June 06 Session - Equities.com
06/08/16 04:48 AM06.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 06.06.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
06/07/16 09:41 AMNew Lifetime High For Emergent BioSolutions (EBS) - TheStreet.com
06/04/16 08:46 AMBiotech Movers: uniQure N.V. (NASDAQ:QURE) , Emergent Biosolutions, Inc. (NYSE:EBS) - Is stories
06/03/16 03:57 PM8699 Shares of Emergent Biosolutions Inc (EBS) Stock are sold by Daniel Abdun-Nabi - Let Me Know About This
06/02/16 05:15 PMContactless Payment Revolution at Erste Bank und Sparkassen - [at noodls] - Exclusive: ATM cash register payment with armband or sticker First NFC-capable ATM in Vienna Launch of BankCardMobil App With immediate effect Erste Bank und Sparkassen are making contactless payments ...
06/01/16 08:43 AMGlobal Payments and CaixaBank Finalize Joint Venture with Erste Group in Central and Eastern Europe - [at noodls] - Global Payments Inc., a leading worldwide provider of payment technology services, and CaixaBank, Spain's largest bank by market share, announced today the completion of the formation of a joint venture ...
06/01/16 08:30 AMNew Lifetime High Reached By Emergent BioSolutions (EBS) - TheStreet.com - New Lifetime High Reached By Emergent BioSolutions (EBS)TheStreet.comEmergent BioSolutions, Inc., a specialty biopharmaceutical company, develops, manufactures, and sells specialized products to healthcare providers and governments in the United States and internationally. EBS has a PE ratio of 18. Currently there are 4 ...Are Analysts Bearish Emergent Biosolutions Inc (NYSE:EBS) After Last Week?Franklin IndependentEmergent Biosolutions, Inc. (NYSE:EBS) Quarterly EBIT At $8.561 MillionsVanguard TribuneEmergent Biosolutions, Inc. Com (EBS) Saw a New 52-Week HighFinance Dailyall 4 news articles »
05/31/16 07:52 AM31.05.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 31.05.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
05/31/16 03:22 AM31.05.2016 - Publication of a transaction regarding Erste Group shares in compliance with section 7 Publication Ordinance (VeröffentlichungsVO) to section 82(9) Austrian Stock Exchange Act (BörseG) considered treasury shares within the mean - [at noodls] - 31.05.2016 - Publication of a transaction regarding Erste Group shares in compliance with section 7 Publication Ordinance (VeröffentlichungsVO) to section 82(9) Austrian Stock Exchange Act (BörseG) considered ...
05/30/16 07:20 AM30.05.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - 30.05.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings The text version of this document ...
05/30/16 03:40 AM27.05.2016 - Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange Act - Changes of significant shareholdings - [at noodls] - Microsoft Word - 160527 - Blackrock_EN.docx Investor information Vienna, 27 May 2016 Announcement pursuant to sec. 93 Austrian Stock Exchange Act in connection with sec. 91 art. 2 Austrian Stock Exchange ...
05/30/16 03:40 AM27.05.2016 - Bekanntmachung gemäß § 93 BörseG in Verbindung mit § 91 Abs. 2 BörseG – Änderungen bedeutender Beteiligungen - [at noodls] - Microsoft Word - 160527 - Blackrock_DE.docx Investoreninformation Wien, 27. Mai 2016 Bekanntmachung gemäß § 93 BörseG in Verbindung mit § 91 Abs. 2 BörseG - Änderungen bedeutender Beteiligungen Die Erste ...
05/28/16 09:31 AMEmergent Biosolutions, Inc. Com (NYSE:EBS) Trading Up – Insider Trading Activity - Here is the rundown on market activity for Emergent Biosolutions, Inc. Com (NYSE:EBS). Chairman Fuad El-hibri sold 39,759 shares at an average price of $43.20 on Thu the 26th. El-hibri now owns $71,664,826 of stock as recorded in a recent Form 4 SEC filing.
About Emergent Biosolutions

Emergent Biosolutions logoEmergent BioSolutions Inc. is a biopharmaceutical company that offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company develops, manufactures and delivers a portfolio of medical countermeasures primarily for government agencies in the areas of biological and chemical threats and emerging infectious diseases (EID). It also develops and commercializes therapeutics in areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Its two operating divisions include Biodefense and Biosciences. The Biodefense division is a pharmaceutical business focused on countermeasures that address public health threats, including chemical, biological, radiological, nuclear and explosives (CBRNE) threats, as well as EID. The Biosciences division is a pharmaceutical business focused on therapeutics in hematology/oncology with secondary on transplantation, infectious disease and autoimmunity.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Biotechnology
  • Sub-Industry: Biotechnology
  • Exchange: NYSE
  • Symbol: EBS
  • CUSIP: 29089Q10
Key Metrics:
  • Previous Close: $29.34
  • 50 Day Moving Average: $40.87
  • 200 Day Moving Average: $37.74
  • P/E Ratio: 15.68
  • P/E Growth: 0.96
  • Market Cap: $1.18B
  • Current Quarter EPS Consensus Estimate: $1.55 EPS
Additional Links:
Emergent Biosolutions (NYSE:EBS) Chart for Saturday, June, 25, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha